Literature DB >> 31431029

Gallbladder cancer: surgical management.

Robert W Krell1, Alice C Wei2.   

Abstract

Gallbladder cancer is the most common biliary tract malignancy. Margin-clearing surgery is a cornerstone of gallbladder cancer management, but several aspects of surgical management are controversial. This review will discuss the current state of surgical management for gallbladder cancer as well as aspects of gallbladder surgery that remain debated, including operative extent, lymphadenectomy extent, and management of incidentally discovered gallbladder cancer.

Entities:  

Keywords:  Gallbladder cancer; hepatectomy; lymphadenectomy

Mesh：

Year:  2019        PMID： 31431029     DOI： 10.21037/cco.2019.06.06

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN： 2304-3865


  11 in total

1.  Routine Histopathological Examination of the Specimen After Laparoscopic Cholecystectomy: Can We Be Brave Enough to Give Up?

Authors:  Ramazan Kozan; Safa Özaydın; Hüseyin Bayhan; Sezai Leventoğlu; Ahmet Karamercan; Ahmet Ziya Anadol; Mustafa Şare; Abdülkadir Bülent Aytaç
Journal:  Turk J Gastroenterol       Date:  2021-02       Impact factor: 1.852

Review 2.  Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer Patients.

Authors:  Patricia García; Angela Lamarca; Javier Díaz; Enrique Carrera; Juan Carlos Roa
Journal:  Cancers (Basel)       Date:  2020-12-07       Impact factor: 6.639

3.  Fangchinoline induces gallbladder cancer cell apoptosis by suppressing PI3K/Akt/XIAP axis.

Authors:  Jiandong Li; Wenda Cen; Chenhao Tong; Luna Wang; Weiguang Zhang; Shiqing Deng; Jianhua Yu; Baochun Lu
Journal:  PLoS One       Date:  2022-04-21       Impact factor: 3.240

4.  Incidental gallbladder cancer: a retrospective clinical study of 40 cases.

Authors:  Merih Altiok; Hanife Gülnihal Özdemir; Feyzi Kurt; Mehmet Onur Gul; Serdar Gumus
Journal:  Ann Surg Treat Res       Date:  2022-04-05       Impact factor: 1.766

Review 5.  Progress in gallbladder cancer with lymph node metastasis.

Authors:  Yuhang Li; Yinghui Song; Yujing Zhang; Sulai Liu
Journal:  Front Oncol       Date:  2022-08-22       Impact factor: 5.738

Review 6.  Overview of current targeted therapy in gallbladder cancer.

Authors:  Xiaoling Song; Yunping Hu; Yongsheng Li; Rong Shao; Fatao Liu; Yingbin Liu
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

7.  Expression analysis of aryl hydrocarbon receptor repressor (AHRR) gene in gallbladder cancer.

Authors:  Puneet Kumar; Manoj Yadav; Khushi Verma; Ruhi Dixit; Juhi Singh; Satyendra K Tiwary; Gopeshwar Narayan; V K Dixit
Journal:  Saudi J Gastroenterol       Date:  2021 Jan-Feb       Impact factor: 2.485

8.  CircPVT1 promotes gallbladder cancer growth by sponging miR-339-3p and regulates MCL-1 expression.

Authors:  Shouhua Wang; Ting Ting Su; Huanjun Tong; Weibin Shi; Fei Ma; Zhiwei Quan
Journal:  Cell Death Discov       Date:  2021-07-26

Review 9.  FAPI PET/CT in the Diagnosis of Abdominal and Pelvic Tumors.

Authors:  Tianshuo Yang; Long Ma; Haodong Hou; Feng Gao; Weijing Tao
Journal:  Front Oncol       Date:  2022-01-04       Impact factor: 6.244

10.  Long Non-coding RNA FIRRE Acts as a miR-520a-3p Sponge to Promote Gallbladder Cancer Progression via Mediating YOD1 Expression.

Authors:  Shuqing Wang; Yang Wang; Shouhua Wang; Huanjun Tong; Zhaohui Tang; Jiandong Wang; Yongjie Zhang; Jingmin Ou; Zhiwei Quan
Journal:  Front Genet       Date:  2021-06-08       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.